NCT05616546View on ClinicalTrials.gov

Bone Marrow and Peripheral Blood Immune Responses Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza Vaccine

The vaccine used in this study will be a licensed seasonal inactivated influenza vaccine for intramuscular injection that is approved by the FDA. Enrolled subjects will receive licensed seasonal inactivated influenza vaccine (administered as a part of the study).

Trial Locations (1)

30322

RECRUITING

Emory University Hospital, Atlanta

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Emory University

OTHER